ESRD

Clinical trials for ESRD explained in plain language.

Never miss a new study

Get alerted when new ESRD trials appear

Sign up with your email to follow new studies for ESRD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1 Completed 3

Can a diabetes drug protect kidneys in advanced disease?

Disease control Ongoing

This study looks at whether canagliflozin, a drug used for diabetes, can safely reduce kidney damage in people with advanced chronic kidney disease (CKD), including those on dialysis. About 35 adults with stage 4 or 5 CKD will take the drug for up to 26 weeks. Researchers will me…

Matched conditions: ESRD

Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control

Last updated May 08, 2026 12:01 UTC

ESRD

Get alerted when new ESRD trials appear

Can a diabetes drug protect kidneys in advanced disease?